show episodes
 
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
  continue reading
 
Host Russ Altman, a professor of bioengineering, genetics, and medicine at Stanford, is your guide to the latest science and engineering breakthroughs. Join Russ and his guests as they explore cutting-edge advances that are shaping the future of everything from AI to health and renewable energy. Along the way, “The Future of Everything” delves into ethical implications to give listeners a well-rounded understanding of how new technologies and discoveries will impact society. Whether you’re a ...
  continue reading
 
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something ...
  continue reading
 
Sounds of Science is a monthly podcast about beginnings: how a molecule becomes a drug, how a rodent elucidates a disease pathway, how a horseshoe crab morphs into an infection fighter. The podcast is produced by Eureka, the scientific blog of Charles River, a contract research organization for drug discovery and development. Tune in and begin the journey.
  continue reading
 
Dr Phil Richardson explores how to solve complex problems in strategy, innovation and change management using business models created from biological systems. Based on 3.8 billion years of evolution biological systems can provide a unique, if not counterintuitive way of thinking differently. The approach has been successfully used in product and service development, creating new ways of working, improving collaboration and delivering disruptive change.
  continue reading
 
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
  continue reading
 
Grow Everything brings to life the bioeconomy when hosts Karl Schmieder and Erum Azeez Khan share stories from the field and interview leaders and influencers in the space. Life is a powerful force and it can be engineered. What will we create? Learn more at www.messaginglab.com/groweverything Topics: synthetic biology, entrepreneurship, policy, community, education, biotech, life sciences
  continue reading
 
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday.The host is Jim Cornall.
  continue reading
 
I
Inside Biotech
Series avatar that links to series pageSeries avatar that links to series page

1
Inside Biotech

Ananta Wadhwa, Kathy Grotsch PhD, Gabriella Rubert, Leo Ying

Unsubscribe
Unsubscribe
Monthly
 
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
  continue reading
 
Welcome to The Biotech Startups Podcast by Excedr. Join us as we speak with first-time founders, experienced scientists, long-time company operators, serial entrepreneurs, and biotech investors about the challenges and triumphs of running a biotech startup. Gain actionable insight into navigating the ever-changing life sciences industry in each episode as we explore the business of science, from pre-seed to IPO. With your host, Jon Chee.
  continue reading
 
A video podcast by the American Society for Microbiology that highlights the latest in microbiology, life science and biotechnology news. ASM is composed of over 42,000 scientists and health professionals with the mission to advance the microbial sciences as a vehicle for understanding life processes and to apply and communicate this knowledge for the improvement of health and environmental and economic well-being worldwide. For information about ASM and MicrobeWorld, visit us online at www. ...
  continue reading
 
Watch the best Europeans in biotech to grow. Hosted by Philip Hemme. 10k monthly views. Free. Guests include Antoine Papiernik from Sofinnova, Werner Lanthaler from Evotec, Ingmar Hoerr from CureVac, Bernat Olle from Vedanta, Johannes Fruehauf from BioLabs, and Rodger Novak from CRISPR Tx. Your host Philip animates the conversation to dig out exciting, and sometimes contrarian ideas.
  continue reading
 
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
  continue reading
 
Vivek Ramaswamy, a product of the American Dream, shares his journey from being a nerdy kid to becoming a biotech entrepreneur and founder of multi-billion-dollar companies. He faced challenges, but never saw hardship as victimhood. Instead, he found opportunities in adversity. After creating successful biotech companies that developed life-saving drugs, Vivek turned his attention to the rise of the ""woke cult"" and woke capitalism, writing best-selling books on these subjects. Ramaswamy de ...
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
  continue reading
 
Anna Kavanaugh hosts the weekly radio series, "Mad Science: The Genetic Crossroad." The program aims to raise awareness and provide education about genetically modified organisms (GMO), in the world food supply and the practices of the GM biotech industry. The series is dedicated to all issues surrounding GM foods, its usage and ramifications thereof. Anna is a writer, advocate, and founder of the (AKCF) Anna Kavanaugh Charitable Foundation. Her original novel, "The Cord of Callows," now an ...
  continue reading
 
Podcast interviews with genius-level (top .1%) practitioners, scientists, researchers, clinicians and professionals in Cancer, 3D Bio Printing, CRISPR-CAS9, Ketogenic Diets, the Microbiome, Extracellular Vesicles, and more. Subscribe today for the latest medical, health and bioscience insights from geniuses in their field(s).
  continue reading
 
From the N.C. Plant Sciences Initiative at NC State comes a podcast that takes a 360° view of emerging agriculture technologies. Join the host, N.C. PSI Executive Director Adrian Percy as he speaks with academic researchers, industry experts, growers, producers, Extension specialists, and others in the agtech community.
  continue reading
 
T
Ticktective
Series avatar that links to series pageSeries avatar that links to series page

1
Ticktective

Bay Area Lyme Foundation

Unsubscribe
Unsubscribe
Monthly
 
Ticktective podcast, a Bay Area Lyme Foundation program, investigates the latest scientific knowledge and advances in Lyme and tick-borne diseases, and offers insightful discussion with researchers, physicians, patients, and thought leaders in the field.
  continue reading
 
In the Decade of Biotech when there will be myriad opportunities to invest in angel-scale biotech startups. After decades of angel investing, I am focusing on the life science side of my portfolio and invite other angels to do the same. Here's why: https://www.labcoatventures.com/why-we-are-focused-on-early-stage-biotech/ I’m Sal Daher, host of the Angel Invest Boston Podcast. After immigrating to Boston as a child and attending Belmont High School, I studied engineering at MIT and Stanford. ...
  continue reading
 
Conversations with clinicians, vendors, policy makers and decision makers to promote innovation and collaboration for better healthcare enabled by technology. Learn about digital health, medical devices, medtech, biotech, health informatics, life sciences, aged care, disability, commercialisation, startups and so much more.
  continue reading
 
Loading …
show series
 
We discuss why AbbVie is spending $10 billion on a cancer-focused company that spent four decades on the path to its first FDA approval, a deal with implications for biotech in 2023 and for a burgeoning area in oncology. We’ll also talk about the latest news in the life sciences, including safety concerns for CAR-T cancer treatment, the slumping in…
  continue reading
 
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. Today we have some exciting news to share with you. Eli Lilly has recently entered into a collaboration with Tokyo-based Prism Biolab to develop small molecule inhibitors of protein-protein interactions. This partner…
  continue reading
 
What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 3.By Moira Gunn
  continue reading
 
“The reality is that the earlier one thinks about and invests in a safety process and a safety system, the more dividends that early thinking pays downstream.” Dr. Greg Fiore Harvard-Trained Physician. McKinsey Consultant. Startup Advisor. These are just a few of the titles that describe our next guest, Dr. Greg Fiore. As one might imagine, with th…
  continue reading
 
Synopsis: Troy Wilson, Ph.D., J.D., is the President and CEO of Kura Oncology, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Troy talks about his experiences being a CEO and the differences in responsibility between being a CEO and a board member. He also shares wha…
  continue reading
 
Welcome to Building Biotechs: A Podcast by Recruitomics Consulting! Here, we offer a behind-the-scenes look into the strategy for launching and scaling successful biotech and life science companies. Today, we chat with Lynn Walder, Founder & Principal of Executive Management Partners and Director of Partnerships Programming at LabCentral. LabCentra…
  continue reading
 
Part 2 of 3. My guest for this week’s episode is Fengru Lin, Founder and CEO of TurtleTree, a biotech company revolutionizing food for good. Having raised a 40 million dollar Series A, TurtleTree is creating cell-based milk, with a current focus on releasing LF+, the world’s first sustainably produced lactoferrin made with cutting-edge precision fe…
  continue reading
 
Artificial intelligence promises to reshape the healthcare landscape and deliver new insights into the molecular drivers of health and wellness, provide rapid diagnoses of patients, and discover and design therapies that extend beyond human imagination. Swaroop ‘Kittu’ Kolluri, founder and managing director of Neotribe Ventures, is using his experi…
  continue reading
 
When it comes to landing and executing strategic partnerships, Regeneron puts on a clinic. Partnerships, acquisitions, licensing agreements, and other deals large and small with Intellia, Decibel Therapeutics, BARDA, Alnylam, and Sonoma Therapeutics are just a sampling of those making news this year alone. The man behind much of that dealmaking is …
  continue reading
 
After 8.5 years of weekly podcasts I'm going to take a 5 week break and plan new episodes for 2024. I'm going through a medical glitch that has me unable to do my normal work. On top of this we're going to switch to an audio plus video format to find a wider audience. So check back in 2024 for the next episode. Have a great rest of 2023, thank you …
  continue reading
 
Tanya Attias is the founder and CEO of MedInt (https://medint.ai), a medical technology startup that is using AI and human experts to create a database to help doctors quickly make decisions based on the latest medical information.Avraham sat down with Tanya to discuss how she came up with the idea, the challenges in building a team, getting invest…
  continue reading
 
Episode Description: Karl and Erum are joined by Gabe and Samet to discuss alternative proteins and the meat market. They highlight the significance of storytelling in biotech to expand the market and the role of early adopters in this process. The conversation touches on the environmental impact of animal agriculture and the advantages of alternat…
  continue reading
 
On this week’s podcast we have a conversation with Jordi Mata-Fink, co-founder and chief executive officer of the newly-launched U.S. company Gate Bioscience. 00:45-01:06: About Gate Bioscience 01:06-02:09: What are disease-causing extracellular proteins? 02:09-04:44: How have diseases caused by extracellular proteins been treated in the past? 04:4…
  continue reading
 
In an era characterized by macro headwinds and profound market volatility, the biotech industry continues to raise capital to fuel drug development, clinical trials, and innovation. Capital raising in challenging markets comes with additional risks, leading venture capital firms and crossover investors to identify creative, unconventional deal stru…
  continue reading
 
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. This week, we’re delighted to be joined by Harry Rickerby, Co-founder of Briefly Bio, a groundbreaking platform he's developing to streamline experimental design in life sciences using large language models (LLMs). Host Ross Katz speaks with …
  continue reading
 
Loading …

Quick Reference Guide